Videos de Experimentos Relacionados

Sólo sobre mi cadáver.

John A Lee¹

¹Department of Histopathology, Rotherham General Hospital, Rotherham S60 2UD, UK. john.lee@rothgen.nhs.uk

Lancet (London, England)

|June 22, 2005

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Same author

Scalable, memory-efficient robust proton therapy optimization through beamlet-free treatment planning.

Medical physics·2025

Same author

Dynamic proton arc treatment planning study for oesophageal cancer.

Physics and imaging in radiation oncology·2025

Same author

Towards faster plan adaptation for proton arc therapy using initial treatment plan information.

Physics and imaging in radiation oncology·2025

Same author

Anticipating potential bottlenecks in adaptive proton FLASH therapy: a ridge filter reuse strategy.

Physics in medicine and biology·2025

Same author

Proton arc therapy plan optimization with energy layer pre-selection driven by organ at risk sparing and delivery time.

Physics in medicine and biology·2025

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Sólo sobre mi cadáver.

Videos de Conceptos Relacionados

Artículos Relacionados

Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold.

Scalable, memory-efficient robust proton therapy optimization through beamlet-free treatment planning.

Dynamic proton arc treatment planning study for oesophageal cancer.

Towards faster plan adaptation for proton arc therapy using initial treatment plan information.

Anticipating potential bottlenecks in adaptive proton FLASH therapy: a ridge filter reuse strategy.

Proton arc therapy plan optimization with energy layer pre-selection driven by organ at risk sparing and delivery time.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

Sólo sobre mi cadáver.

Videos de Conceptos Relacionados

Artículos Relacionados

Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold.

Scalable, memory-efficient robust proton therapy optimization through beamlet-free treatment planning.

Dynamic proton arc treatment planning study for oesophageal cancer.

Towards faster plan adaptation for proton arc therapy using initial treatment plan information.

Anticipating potential bottlenecks in adaptive proton FLASH therapy: a ridge filter reuse strategy.

Proton arc therapy plan optimization with energy layer pre-selection driven by organ at risk sparing and delivery time.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.